2023
DOI: 10.1002/acn3.51895
|View full text |Cite
|
Sign up to set email alerts
|

Evidence‐based consensus guidelines for ALS genetic testing and counseling

Jennifer Roggenbuck,
Breda H. F. Eubank,
Joshua Wright
et al.

Abstract: ObjectiveAdvances in amyotrophic lateral sclerosis (ALS) gene discovery, ongoing gene therapy trials, and patient demand have driven increased use of ALS genetic testing. Despite this progress, the offer of genetic testing to persons with ALS is not yet “standard of care.” Our primary goal is to develop clinical ALS genetic counseling and testing guidelines to improve and standardize genetic counseling and testing practice among neurologists, genetic counselors or any provider caring for persons with ALS.Metho… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(1 citation statement)
references
References 101 publications
(377 reference statements)
0
1
0
Order By: Relevance
“…Training curricula for neurology clinicians need revision to include relevant aspects of genomics, and educational resources (eg, the NHS Genomics Education Programme) could be updated to include details on more complex aspects of MND genomic testing and clinician guidelines produced. 16 17 Additionally, neurology clinicians cited a lack of resources to support genomic testing discussions for pwMND, which suggests that pwMND may lack important information and guidance when considering genomic testing options. Resources such as information leaflets, videos or patient decision aids could be developed to fill this gap.…”
Section: Discussionmentioning
confidence: 99%
“…Training curricula for neurology clinicians need revision to include relevant aspects of genomics, and educational resources (eg, the NHS Genomics Education Programme) could be updated to include details on more complex aspects of MND genomic testing and clinician guidelines produced. 16 17 Additionally, neurology clinicians cited a lack of resources to support genomic testing discussions for pwMND, which suggests that pwMND may lack important information and guidance when considering genomic testing options. Resources such as information leaflets, videos or patient decision aids could be developed to fill this gap.…”
Section: Discussionmentioning
confidence: 99%